💨 Abstract

Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday, driven by strong sales, especially in the key North American market.consolidated profit rose to 1.78 billion rupees ($21.3 million) in the three months ended March 31, from 1.53 billion a year earlier. thePrint holds no responsibilty for its content.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖